Trial Profile
Impact of an Integrated Intervention Program on Adherence to Atorvastatin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Pfizer
- 05 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2011 Planned end date changed from Dec 2011 to Nov 2011 as reported by ClinicalTrials.gov.
- 01 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.